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OBJECTIVES This study was designed to identify echocardiographic predictors of aortopulmonary
collaterals (APCs) in infants with tetralogy of Fallot and pulmonary atresia (TOF/PA) and
to prospectively validate these predictors.
BACKGROUND In patients with TOF/PA, routine preoperative diagnostic cardiac catheterization is usually
performed to determine the presence and distribution of APCs and the anatomy of the branch
pulmonary arteries.
METHODS The clinical and diagnostic imaging data of infants with TOF/PA treated between 1990 and
2000 were reviewed. Patients were classified into two groups based on cineangiographic
findings: 1) no APCs (n 34), and 2)1 APCs (n 59). Echocardiographic variables were
examined for their ability to identify patients having 1 APCs.
RESULTS Median branch pulmonary artery diameter Z scores were significantly larger in patients
without APCs compared with those having 1 APCs: 0.56 versus 3.24 for the left
pulmonary artery and 0.76 versus 3.46 for the right pulmonary artery (p  0.001). The
presence of a branch pulmonary artery diameter Z score 2.5 was 88% sensitive and 100%
specific for the presence of1 APCs. Detection of APCs by color Doppler was 93% sensitive
and 91% specific. A combination of branch pulmonary artery diameter Z score 2.5 or
patent ductus arteriosus diameter 2 mm was 97% sensitive and 100% specific for the
presence of 1 APCs. The diagnostic accuracy of these echocardiographic variables was
subsequently validated in a prospective study of 11 infants.
CONCLUSIONS Echocardiography is a sensitive and specific test for the detection of1 APCs in infants with
TOF/PA. These data can be used to select patients who can undergo complete repair of
TOF/PA without further preoperative diagnostic imaging. (J Am Coll Cardiol 2003;41:
852–7) © 2003 by the American College of Cardiology Foundation
In infants with tetralogy of Fallot and pulmonary atresia
(TOF/PA), the central pulmonary arteries may be hypo-
plastic, discontinuous, or absent, and the pulmonary vascu-
lar bed may be supplied with blood flow from a patent
ductus arteriosus (PDA), from aortopulmonary collaterals
(APCs), or from a combination of both (1–3). Surgical
management of these infants has evolved over the past 15
years with a tendency towards primary complete repair that
includes closure of the ventricular septal defect, right
ventricle-to-pulmonary artery patch or conduit, and, when
present, recruitment of as many APCs as possible (4).
Preoperative knowledge of all sources of pulmonary blood
supply and the anatomy of the central pulmonary arteries is
therefore essential for surgical planning. Cardiac catheter-
ization has been the standard method for the diagnosis of
APCs in infants with TOF/PA (5,6). However, in new-
borns and young infants with cyanotic congenital heart
disease, cardiac catheterization has significant disadvan-
tages, including risks of morbidity, mortality, and subse-
quent occlusion of blood vessels used for vascular access
(7–9). Because of these drawbacks and the likely need for
additional postoperative transcatheter diagnostic and inter-
ventional procedures such as pulmonary artery dilations,
noninvasive preoperative triage of infants with TOF/PA
into those with and without APCs is desirable.
Previous reports have shown that two-dimensional and
color Doppler echocardiography can accurately delineate the
anatomy of the central pulmonary arteries in infants with
TOF/PA (10,11). However, the sensitivity, specificity, and
predictive values of echocardiography at distinguishing be-
tween infants with and without APCs have not been
investigated. The present study, therefore, was undertaken
to examine the following hypotheses: 1) the extent of APCs
is inversely related to the diameters of the central pulmonary
arteries, and 2) transthoracic echocardiography can serve as
a diagnostic test for the detection of APCs in infants with
TOF/PA.
METHODS
Study design and patients. The study included two com-
ponents. First, echocardiographic variables predictive of 1
APCs were identified in a cross-sectional study of 93 infants
with TOF/PA managed between January 1, 1990, and
August 1, 2000. Patients were identified using the comput-
erized database of the Cardiovascular Program at Children’s
Hospital Boston. Patients were included if they met the
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following criteria: 1) age at diagnosis 1 year, 2) cinean-
giogram available for review, 3) preoperative echocardio-
gram available for review, and 4) no surgical procedure
preceding the initial echocardiogram. In the second phase of
the study, the echocardiographic variables identified to be
predictive of APCs in the cross-sectional study were vali-
dated by prospectively applying them to infants with
TOF/PA treated between August 2000 and July 2002. The
Committee on Clinical Investigation at Children’s Hospital
gave permission to conduct a medical record and database
review.
Echocardiography. Echocardiograms were performed us-
ing several commercially available cardiac ultrasound scan-
ners. The examination protocol included two-dimensional
and Doppler imaging from the subxiphoid, apical, paraster-
nal, and suprasternal views, with particular attention to the
morphology of the right ventricular outflow tract, main and
branch pulmonary arteries, PDA, and evidence of APCs
by color Doppler flow mapping. Studies were recorded on
1.27 cm (0.5 in.) super-VHS videocassette tapes. Most
echocardiograms were performed under either oral chloral
hydrate or intravenous sedation. All preoperative echocar-
diograms were reviewed offline by an investigator who was
unaware of the findings at catheterization, surgery, or
postmortem examination. Measurements were performed
using electronic calipers on a cardiac ultrasound scanner. To
assess interobserver variability, a subset of 14 echocardio-
grams was randomly selected for review by a second observer
who was unaware of the findings of the first investigator.
The diameters of the left pulmonary artery (LPA) and
right pulmonary artery (RPA) were measured from two-
dimensional images in the parasternal short-axis view as
shown in Figure 1. This view was also used to document
LPA-to-RPA direct continuity and to determine the pres-
ence or absence of a main pulmonary artery. The PDA was
imaged from a high parasternal or a suprasternal notch
window and its smallest caliber, usually at the pulmonary
end, was measured from color Doppler flow images. A PDA
was defined as a vessel connecting the undersurface of the
aortic isthmus with the pulmonary artery bifurcation. In
patients with a right aortic arch, a left-sided PDA may arise
from the proximal left subclavian artery ending at the
pulmonary artery bifurcation. An APC was defined as a
vessel that connects the descending aorta or one of the
brachiocephalic arteries with a pulmonary termination ei-
Abbreviations and Acronyms
APCs  aortopulmonary collaterals
BSA  body surface area
LPA  left pulmonary artery
PDA  patent ductus arteriosus
ROC  receiver-operator characteristic
RPA  right pulmonary artery
TOF/PA  tetralogy of Fallot and pulmonary atresia
Figure 1. Measurement of branch pulmonary artery diameters from the parasternal short-axis view. Ao aorta; LPA left pulmonary artery; RPA right
pulmonary artery.
853JACC Vol. 41, No. 5, 2003 Mackie et al.
March 5, 2003:852–7 Predictors of APCs
ther at the distal branch pulmonary arteries or within the
lung parenchyma. All transthoracic and subcostal views
were used to detect APCs by color Doppler flow mapping.
The following variables were recorded: demographics;
weight; height; body surface area (BSA); the smallest
diameters of the LPA, RPA, and PDA; presence or absence
of a main pulmonary artery; presence or absence of APCs by
color Doppler; and whether the proximal branch pulmonary
arteries were in direct continuity. The diameters of the
branch pulmonary arteries were adjusted to BSA and were
expressed as Z scores. The lowest Z score of the group was
assigned to patients with an absent branch pulmonary
artery. Normal control values were obtained from 138
subjects without known heart disease whose age ranged
from birth to 18 years and whose BSA ranged from 0.18 to
2.1 m2.
Catheterization. An experienced pediatric interventional
cardiologist, blinded to the echocardiographic findings,
reviewed the cineangiograms. Cardiac catheterization find-
ings were used as the reference standard to classify patients
into one of the following groups: 1) no APCs, and 2) 1
APCs.
Statistical analysis. Continuous variables are presented as
median values and range. Demographic and echocardio-
graphic variables were compared for patients in the two
outcome groups using the Wilcoxon rank-sum test for
continuous variables and Fisher exact test for categorical
variables. Sensitivity, specificity, and positive and negative
predictive values with 95% confidence limits were calculated
to assess the ability of echocardiography to identify patients
having1 APCs. Interobserver reliability of LPA and RPA
measurements was analyzed using a paired t test. A receiver-
operator characteristic (ROC) curve was used to identify
which pulmonary artery Z score provided the best combi-
nation of sensitivity and specificity for predicting the pres-
ence of APCs, and also to quantify the predictive power of
additional echocardiographic variables. A commercially
available statistical package was used for data analysis
(STATA version 6.0, College Station, Texas).
RESULTS
Cross-sectional study. Of the 93 patients who fulfilled
inclusion criteria, 34 (37%) were classified as having no
APCs and 59 (63%) were classified as having 1 APCs.
Their demographic characteristics and the reference stan-
dards used to classify them are summarized in Table 1.
Echocardiographic variables. Figure 2 shows the Z scores
of the smallest diameters of the branch pulmonary arteries
in patients with no APCs compared with those having 1
APCs. The median LPA diameter Z score was significantly
larger in patients without APCs compared with those
Table 1. Demographic Characteristics and Reference Standards in 93 Infants With TOF/PA
No APCs (n  34) >1 APCs (n  59) p Value
Median age at echo (days) (range) 1 (0.5–129) 57 (0.5–323)  0.001
Median weight (kg) (range) 3.0 (1.0–5.0) 4.2 (1.3–8.0)  0.001
Median BSA (m2) (range) 0.21 (0.10–0.29) 0.25 (0.13–0.40)  0.001
Male gender (%) 59% 49% 0.40
Reference standard
Preoperative catheterization 19 (56%) 51 (86%) 0.002
Postoperative catheterization 15 (44%) 8 (14%)
APCs  aortopulmonary collaterals; BSA  body surface area; TOF/PA  tetralogy of Fallot/pulmonary atresia.
Figure 2. Comparison of branch pulmonary artery diameter Z score between patients with1 aortopulmonary collaterals (APCs) and those without APCs.
Circles represent individual data points. The median values and the corresponding 10th to 90th percentiles are shown for each group. LPA  left
pulmonary artery; RPA  right pulmonary artery.
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having1 APCs (0.56 [2.30 to 1.07] vs.3.24 [4.74
to 3.64], p  0.001), as was the median RPA diameter
Z score (0.76 [2.37 to 0.54] vs. 3.46 [5.53 to 0.62],
p  0.001). Confluent branch pulmonary arteries were
demonstrated by echocardiography in all patients having no
APCs. One or both branch pulmonary arteries were not
visualized in 21 (36%) of the 59 patients with 1 APCs
(p  0.001). Of those 21 patients in whom a branch
pulmonary artery was not visualized by echocardiography,
12 had a diminutive branch pulmonary artery identified by
angiography or at surgery. Presence of APCs by color
Doppler flow mapping was suspected in 3 of 34 patients
(9%) without APCs (false positive) and in 54 of 58 patients
(93%) having 1 APCs (p  0.001). A PDA was detected
in 6 of 58 patients (10%) having 1 APCs and in all 34
patients having no APCs (p  0.001).
Interobserver variability. The mean ( standard error)
interobserver differences in measurements of the smallest
diameter of the branch pulmonary arteries were 0.02 0.06
mm for the LPA and 0.04  0.08 mm for the RPA (p 
0.71 and 0.58, respectively).
Echocardiographic predictors of APCs. Using an ROC
curve, an LPA or RPA Z score value 2.5, compared to
other Z score values, maximized the sensitivity and speci-
ficity for identifying patients having 1 APCs (Fig. 3).
Consequently, this Z value was selected for all subsequent
analyses of the predictive value of branch pulmonary artery
diameter. In infants with a BSA of 0.2 m2, a Z score of
2.5 corresponds to an LPA diameter of 2.0 mm and an
RPA diameter of 2.5 mm. In infants with a BSA of 0.25 m2,
a Z score of 2.5 corresponds to an LPA diameter of 2.5
mm and a RPA diameter of 3.0 mm. Table 2 summarizes
the test characteristics of several echocardiographic variables
with regard to their ability to detect patients having
1 APCs. Branch pulmonary artery diameter Z score
2.5, PDA diameter 2 mm, and evidence for APCs by
color Doppler flow mapping were all highly sensitive and
specific at identifying patients having 1 APCs (area under
the ROC curve 0.92). A combination of individual
variables yielded a better predictive profile than each vari-
able separately. The area under the ROC curve was highest
(0.98) for the combination of branch pulmonary artery
diameter Z score 2.5 or a PDA diameter 2 mm. The
same prediction model was found also to be sensitive and
specific in the subgroup of patients with confluent branch
pulmonary arteries, with an area under the ROC curve of
0.89 for branch pulmonary artery diameter Z score 2.5,
0.92 for evidence for APCs by color Doppler, and 0.94 for
a PDA diameter 2 mm.
Prospective validation study. Of the 11 infants with
TOF/PA who were managed between August 2000 and
July 2002 and who had either a catheterization or magnetic
resonance angiography, 5 (45%) had no APCs based on
reference standards. These five patients were correctly iden-
tified by LPA and RPA diameter Z scores 2.5; all had
a PDA2 mm, and four had no evidence of APCs by color
Doppler. Of the six (55%) patients with 1 APCs by
reference standards, all had APCs by color Doppler, all had
a PDA 2 mm, and five met the criteria of one or both
branch pulmonary artery diameter Z scores 2.5. Using
the combination of branch pulmonary artery diameter
Z score 2.5 or PDA 2 mm to predict a patient having
1 APCs, all 11 patients were correctly classified.
DISCUSSION
The results of this study demonstrate that in unoperated
infants with TOF/PA, transthoracic echocardiography can
Figure 3. Receiver-operator characteristic curve of branch pulmonary artery diameter Z score. Left or right pulmonary artery diameter Z score 2.5 had
the maximum sensitivity and specificity for identifying patients having 1 aortopulmonary collaterals.
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be used to differentiate between patients with and without
APCs. Specifically, branch pulmonary artery diameter
Z score 2.5, PDA diameter 2 mm, and evidence of
APCs by color Doppler flow mapping were each sensitive
and specific tests with an area under the ROC curve ranging
from 0.92 to 0.97. The test performance of transthoracic
echocardiography further improved when a branch pulmo-
nary artery diameter Z score 2.5 or PDA diameter
2 mm were combined, yielding 97% sensitivity and 100%
specificity.
The concept that branch pulmonary artery diameter is
inversely related to the extent of APCs in TOF/PA has
been previously demonstrated in an autopsy study (12).
Acherman et al. (11) demonstrated that patients having a
PDA had larger branch pulmonary arteries than patients
having no PDA and that the main sources of pulmonary
blood flow in this disease can be determined by echocardi-
ography. In a study based on cineangiography, Hadjo et al.
(13) found a significantly higher McGoon ratio (ratio of the
combined diameters of the branch pulmonary artery divided
by the diameter of the descending aorta at the level of the
diaphragm) in patients having pulmonary blood supply
solely through a PDA compared with patients having
1 APCs. The usefulness of color Doppler echocardiogra-
phy in the assessment of APCs in infants with TOF/PA has
been previously demonstrated (10,11). Smyllie et al. (10)
reported that the use of color Doppler flow mapping
resulted in improved sensitivity of the definition of pulmo-
nary blood supply compared to two-dimensional echocardi-
ography alone. However, they also found that color Doppler
flow mapping falsely suggested the presence of APCs in
16% of patients who were found by cineangiography to have
no APCs. The results of the present study are in agreement
with those of Smyllie et al., with 9% of patients without
APCs by reference standards having being misidentified
(false positive). These observations likely reflect the highly
sensitive nature of color Doppler flow mapping. It is
possible that flow signals from bronchial and intercostal
arteries may have been confused with APCs.
Clinical implications. The continued trend towards pri-
mary complete repair of TOF/PA in infancy has reinforced
the importance of accurate delineation of all sources of
pulmonary blood supply prior to surgery (4). Cardiac
catheterization with X-ray angiography has been routinely
performed before surgical repair (4–6). The results of this
study indicate that transthoracic echocardiography can reli-
ably identify infants with TOF/PA who are unlikely to have
APCs and have confluent central pulmonary arteries. Pre-
vious experience indicates that these patients can undergo
surgical repair without a preoperative cardiac catheterization
(14). For patients identified by transthoracic echocardiog-
raphy as being at risk for APCs and/or branch pulmonary
artery discontinuity, magnetic resonance angiography pro-
vides a safe and accurate noninvasive alternative to cathe-
terization (15,16). In our opinion, use of cardiac catheter-
ization can be limited to the minority of patients with
excessive APCs and pulmonary overcirculation in whom
preoperative coil occlusion of the collaterals is deemed
necessary.
The diagnostic approach described here for infants with
TOF/PA has several advantages that are worth noting. The
majority of these patients undergo cardiac catheterization
later in life, including interventional procedures such as
balloon dilation or stent placement for relief of pulmonary
artery stenosis (17,18). Avoiding a preoperative catheteriza-
tion has several potential advantages including reduced risks
of morbidity and mortality, avoiding ionizing radiation
exposure, preserving vascular access for future interventional
catheterization procedures, and lower cost (7–9,19).
Table 2. Diagnostic Test Characteristics of Echocardiographic Variables (95% Confidence Intervals)
Predictor of >1 APCs Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Area Under
ROC Curve
Branch pulmonary artery diameter Z 2.5 88 (77, 95) 100 (90, 100) 100 (93, 100) 83 (68, 93) 0.94
Branch pulmonary artery diameter Z 2 95 (86, 99) 82 (65, 93) 90 (80, 96) 90 (74, 98) 0.89
APCs by color Doppler 93 (83, 98) 91 (76, 98) 95 (85, 99) 89 (73, 97) 0.92
PDA diameter 2 mm 93 (83, 98) 100 (89, 100) 100 (93, 100) 89 (74, 97) 0.97
Branch pulmonary artery diameter Z 2.5 or PDA
diameter 2 mm
97 (88, 100) 100 (89, 100) 100 (94, 100) 94 (80, 99) 0.98
PDA diameter 2 mm or APCs by color Doppler 97 (88, 100) 91 (75, 98) 95 (86, 99) 94 (79, 99) 0.94
Branch pulmonary artery diameter Z 2.5 or APCs
by color Doppler
97 (88, 100) 91 (76, 98) 95 (86, 99) 94 (80, 99) 0.93
Branch pulmonary artery diameter Z 2.5 or APCs
by color Doppler or PDA diameter 2 mm
98 (91, 100) 91 (75, 98) 95 (86, 99) 97 (83, 100) 0.95
Branch pulmonary artery diameter Z 2.5 and PDA
diameter 2 mm
86 (75, 94) 100 (89, 100) 100 (93, 100) 80 (64, 91) 0.93
PDA diameter 2 mm and APCs by color Doppler 89 (78, 96) 100 (89, 100) 100 (93, 100) 84 (69, 94) 0.95
Branch pulmonary artery diameter Z 2.5 and
APCs by color Doppler
84 (73, 93) 100 (90, 100) 100 (93, 100) 79 (64, 90) 0.92
Branch pulmonary artery diameter Z 2.5 and
APCs by color Doppler and PDA diameter 2 mm
84 (72, 92) 100 (89, 100) 100 (93, 100) 78 (62, 89) 0.92
APCs aortopulmonary collaterals; NPV negative predictive value; PDA patent ductus arteriosus; PPV positive predictive value; ROC receiver-operator characteristic.
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Study limitations. The confounding effect of prostaglan-
din E on PDA and branch pulmonary artery diameters
could not be reliably assessed. For example, in a number of
patients who underwent an echocardiogram during the first
1 to 2 days of life, prostaglandin E was started during the
examination once the presence of pulmonary atresia was
established. We also recognize the often long and tortuous
nature of the ductus arteriosus in TOF/PA. We therefore
chose to measure its caliber at the pulmonary end because
measurements in this location are likely more reproducible.
However, other variables such as length also influence the
amount of pulmonary blood flow through the ductus arte-
riosus.
Conclusions. Echocardiography is a sensitive and specific
diagnostic test for the presence of APCs in infants with
TOF/PA. The presence of a branch pulmonary artery
diameter Z score 2.5 or a PDA diameter 2 mm is the
most sensitive and specific test for the presence of 1
APCs. Infants with TOF/PA who have confluent branch
pulmonary arteries with a minimal diameter Z score2.5
and a minimal PDA diameter 2 mm by echocardiography
are unlikely to have APCs and can undergo surgical repair
without a preoperative cardiac catheterization.
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